John Lo

Chief Commercial Officer (CCO), Beam Therapeutics

As Chief Commercial Officer at Beam Therapeutics, John Lo focuses on commercial strategy for gene therapy programs, including treatments under development for sickle cell disease and alpha-1 antitrypsin deficiency.